Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
2S albumins are a major family of seed storage proteins widely distributed in dicotyledonous plants, including legumes, tree nuts, and oilseeds [1]. Characterized by their small molecular weight (approximately 10-15 kDa) and a conserved motif of eight cysteine residues forming four stabilizing disulfide bonds, these proteins are remarkably resistant to thermal denaturation and proteolytic digestion [1,2]. Biologically, they serve as essential reservoirs of nitrogen and sulfur that are mobilized by the plant embryo during the germination process [2]. In clinical medicine, 2S albumins are primarily significant as potent food allergens; they are frequently identified as 'major' allergens because they are recognized by IgE antibodies in a high percentage of allergic individuals and often correlate with severe systemic reactions and anaphylaxis [3]. While they do not serve as traditional therapeutic targets for enzymatic inhibition or receptor modulation, they are the primary focus of component-resolved diagnostics (CRD) and are the active components in allergen-specific immunotherapy (AIT) products, such as Palforzia, which aims to induce oral tolerance in patients with peanut allergy [4]. Sources: [1] Moreno and Clemente (2008) PMID: 18435102; [2] Shewry et al. (1995) PMID: 7712111; [3] Hauser et al. (2008) PMID: 18312571; [4] FDA Palforzia Prescribing Information (2020).
Induction of oral tolerance and immunological desensitization through controlled, escalating exposure to the allergen, leading to increased IgG4 levels and reduced IgE-mediated mast cell activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 2S albumin seed storage protein (2S albumin).